FK 506 induction and rescue therapy in pancreas transplant recipients.
Stratta
R J
RJ
University of Nebraska Medical Center, Omaha 68198-3280, USA.
Taylor
R J
RJ
Castaldo
P
P
Sindhi
R
R
Sudan
D
D
Weide
L G
LG
Frisbie
K
K
Cushing
K A
KA
Jerius
J
J
Radio
S J
SJ
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology; D016035:Pancreas Transplantation / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus